Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

J. Anderson, Evan; Rouphael, Nadine; T. Widge, Alicia; A. Jackson, Lisa; C. Roberts, Paul; Makhene, Mamodikoe; D. Chappell, James; R. Denison, Mark; J. Stevens, Laura; J. Pruijssers, Andrea; B. McDermott, Adrian; Flach, Britta; C. Lin, Bob; A. Doria‐Rose, Nicole; O’Dell, Sijy; D. Schmidt, Stephen; S. Corbett, Kizzmekia; A. Swanson, Phillip; Padilla, Marcelino; M. Neuzil, Kathy; Bennett, Hamilton; Leav, Brett; Makowski, Mat; Albert, Jim; Cross, Kaitlyn; Viswanadh Edara, Venkata; Floyd, Katharine; S. Suthar, Mehul; Martínez, David; S. Baric, Ralph; Buchanan, Wendy; J. Luke, Catherine; K. Phadke, Varun; A. Rostad, Christina; E. Ledgerwood, Julie; S. Graham, Barney; H. Beigel, John

doi:10.1056/nejmoa2028436

Public

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

Published in New England Journal of Medicine • Sep 29, 2020

Authors:

Evan J. Anderson

Nadine Rouphael

Alicia T. Widge

Abstract

BACKGROUND: Testing of vaccine candidates to prevent infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since increased incidences of illness and death from coronavirus disease 2019 (Covid-19) have been associated with an older age. METHO...

Subject

Immunogenicity

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Virology

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!